Page 144 - கனடா ஓய்வூதியம் திட்டம் முதலீடு பலகை News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Company Update - Cadila Healthcare - ICICI Direct
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Health and Beauty Retailer Super-Pharm Commits Ecommerce Strategy to Micro-Fulfillment With Expansion of Partnership with Fabric
multichannelmerchant.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multichannelmerchant.com Daily Mail and Mail on Sunday newspapers.
Share this article
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISTRIBUTION IN THE UNITED STATES./
TORONTO, May 12, 2021 /CNW/ - Tricon Residential Inc. (TSX: TCN) ( Tricon or the Company ), an owner and operator of single-family rental homes and multi-family rental apartments in the United States and Canada, announced today its consolidated financial results for the three months ended March 31, 2021. The Company also provided an update on recent operating trends. All financial information is presented in U.S. dollars unless otherwise indicated.
The Company reported strong operational and financial results in the first quarter, including the following highlights:
Net income from continuing operations was $41.9 million compared to a net loss of $46.5 million in the prior year; diluted earnings per share from continuing operations was $0.21 compared to a $0.24 loss per share in the prior year;
To embed, copy and paste the code into your website or blog:
Sixth Street has led an $830 million growth equity investment into Caris Life Sciences, according to a news release.
Caris, based in Irving, Texas, develops molecular profiling assays for oncology that scan DNA, RNA and proteins to reveal a molecular blueprint intended to help physicians and patients make more precise and personalized cancer treatment decisions.
Sixth Street, based in San Francisco, is a global investment firm. Founded in 2009, the firm’s healthcare and life sciences team provides strategic growth capital tailored to healthcare and pharma business timelines including to develop or launch new medicines, make asset acquisitions and fund strategic projects.
vimarsana © 2020. All Rights Reserved.